Download
10.1186_s40463-020-00433-6.pdf 777,19KB
WeightNameValue
1000 Titel
  • 33% hydrogen peroxide as a Neoadjuvant treatment in the surgical excision of non-melanoma skin cancers: A case series
1000 Autor/in
  1. Mundi, Neil |
  2. Jordan, K. |
  3. Doyle, P. |
  4. Moore, C. |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-01-01
1000 Erschienen in
1000 Quellenangabe
  • 49(1)
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s40463-020-00433-6 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268291/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:sec><jats:title>Background</jats:title><jats:p> Hydrogen peroxide (H<jats:sub>2</jats:sub>O<jats:sub>2</jats:sub>) is a product of respiration in mitochondria and an important oxidizing agent in biological systems. Previous investigations have shown the efficacy of H<jats:sub>2</jats:sub>O<jats:sub>2</jats:sub> in treating skin conditions such as seborrheic keratosis and actinic keratosis. In an area like the face, reconstruction of excision defects and ultimately aesthetic outcomes are of utmost importance. Hydrogen peroxide may represent a simple yet effective method at shrinking non-melanoma skin cancers (NMSC) of the head and neck before they are excised. </jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p> Eleven consecutive patients presenting to our cutaneous malignancy clinic had their skin lesions evaluated by the senior author for participation in the study. Lesion length and width was measured. Hydrogen peroxide formulated at a concentration of 33% was rubbed into the lesion until blanching was observed. Lesions were re-measured at follow up. Excisional biopsy was then performed and histopathological diagnosis was obtained. Statistical analyses compared pre- and post-treatment lesion dimensions. </jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p> Seventeen biopsy-proven NMSC lesions were included in this investigation. Statistically significant reductions in the length ( p &lt; 0.001) and width ( p &lt; 0.001) were observed with H<jats:sub>2</jats:sub>O<jats:sub>2</jats:sub> treatment. For some lesions, H<jats:sub>2</jats:sub>O<jats:sub>2</jats:sub> was the sole treatment required, with post-treatment biopsy demonstrating no evidence of malignancy. Patients endured minimal discomfort during treatment and no long-term side effects were observed. Follow up at 6 months revealed no recurrences. </jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p> We have demonstrated a significant reduction in the size of multiple lesions after application of 33% hydrogen peroxide, simplifying definitive excision and reconstruction. Hydrogen peroxide demonstrated an ability to successfully treat non-melanoma skin cancers as well. </jats:p></jats:sec>
1000 Sacherschließung
lokal Peroxide
lokal Female [MeSH]
lokal Hydrogen Peroxide/administration
lokal Hydrogen Peroxide/therapeutic use [MeSH]
lokal Aged, 80 and over [MeSH]
lokal Carcinoma, Basal Cell/drug therapy [MeSH]
lokal Aged [MeSH]
lokal Biopsy [MeSH]
lokal Humans [MeSH]
lokal Margins of Excision [MeSH]
lokal Middle Aged [MeSH]
lokal Skin Neoplasms/drug therapy [MeSH]
lokal Carcinoma, Basal Cell/pathology [MeSH]
lokal Administration, Cutaneous [MeSH]
lokal Skin Neoplasms/pathology [MeSH]
lokal Carcinoma, Basal Cell/surgery [MeSH]
lokal Carcinoma, Squamous Cell/drug therapy [MeSH]
lokal Neoadjuvant Therapy [MeSH]
lokal Male [MeSH]
lokal Carcinoma, Squamous Cell/surgery [MeSH]
lokal Carcinoma, Squamous Cell/pathology [MeSH]
lokal Original Research Article
lokal Skin Neoplasms/surgery [MeSH]
lokal Skin neoplasms
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0001-9328-8266|https://frl.publisso.de/adhoc/uri/Sm9yZGFuLCBLLg==|https://frl.publisso.de/adhoc/uri/RG95bGUsIFAu|https://frl.publisso.de/adhoc/uri/TW9vcmUsIEMu
1000 Hinweis
  • DeepGreen-ID: fcbd072cc6b34e6d82581b9bde5415f0 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6476708.rdf
1000 Erstellt am 2024-05-14T14:03:04.719+0200
1000 Erstellt von 322
1000 beschreibt frl:6476708
1000 Zuletzt bearbeitet Wed May 15 07:41:08 CEST 2024
1000 Objekt bearb. Wed May 15 07:41:08 CEST 2024
1000 Vgl. frl:6476708
1000 Oai Id
  1. oai:frl.publisso.de:frl:6476708 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source